A Peek Inside Progress

As the New Year rises, a hopeful horizon brightens for Cure JM. It is with great thanks to our Cure JM community for your extraordinary commitment to funding new research as we move into 2024. Celebrate the achievements with us and review our community’s impact and our goals for the new year.

Jim Minow, Executive Director, updates on recent research breakthroughs, new treatment options, and plans to expand Cure JM’s Clinical Care Network.

Andrew Heaton, Chief Scientific Officer, updates families with the latest information on new treatments on the horizon, including deucravacitinib and vamorolone.

Shannon Malloy, Director of Family and Community Engagement, discusses the latest developments in physician education programs, family education and support programs, and our plans for family connections in the coming year.

Click the image above to watch the informative presentation.

May 2025 Town Hall, Dr. Ardalan

Tapering Medication

Cure JM hosted a special Town Hall featuring Dr. Kaveh Ardalan, Co-Director of the Duke Children’s Myositis Center, a Cure JM Center of Excellence. The

Olivia's Story of Hope, photo of family

Olivia’s Story

Olivia is four years old, and she’s been fighting juvenile myositis for almost two years. At the beginning of her treatment, Olivia’s parents, Leah and

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.

Cure JM supports families, patients, and the juvenile myositis research community.

Interested in DIY fundraising but need help?

We’re here to help!

To have your fundraiser matched, add “DIY Match” in the memo of your online gift or check.